Jun 06, 2023 8:00am EDT iBio Expands Tech Stack with EngageTx™; Adds TROP-2 Bispecific to Development Pipeline
Apr 04, 2023 4:05pm EDT iBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform
Jan 05, 2023 8:00am EST iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine
